6ER-026 Spectrum of heart failure in 16 sub-Saharan African countries: treatments and in-hospital outcome

• Published in: European journal of hospital pharmacy. Science and practice 2023-03, Vol.30 (Suppl 1), p.A167-A168
• Main Authors: Cavagna, P, Kouam Kouam, C, Diop, IB, Limbole, E, Allawaye, L, Takombe, JL, Traore, AK, N’Guetta, R, Ikama, MS, Jouven, X, Antignac, M
• Format: Article
• Language: English
• Subjects: Anticoagulants; Conflicts of interest; Diuretics; Drugs; Heart failure; Hospitalization; Length of stay; Patients; Section 6: Education and research
• ISSN: 2047-9956; 2047-9964
• DOI: 10.1136/ejhpharm-2023-eahp.349

Background and ImportanceHeart failure (HF) is the most common primary diagnosis for patients admitted to hospital with heart disease in sub-Saharan Africa (SSA). However, little is known about the management of HF in hospitalisation in SSA.Aim and ObjectivesTo describe in hospital drugs strategies to manage HF in 36 cardiovascular (CV) departments.Material and MethodsWe conducted a transversal and longitudinal study in CV departments of 36 hospital (public and private) in 16 SSA countries. The February study is an ongoing observatory included all inpatients in February from each year since 2016. Data including socio-demographic and clinical characteristics, CV risk factors, causes of admission, medication and length of stay were collected during hospitalisation by physicians. Patient wealth index was assessed by physicians as low, middle and high according to patient capacity to afford hospitalisation. All analyses were performed with random effect on countries and through scripts developed in the R software 4.0.3.ResultsOverall, 2084 patients were admitted for HF in the February study. HF representing 47.9% of all patients included. The mean age was 57 ± 17.4 years and 53.8% were men. Proportions of patients admitted for HF varied across countries from 21.4% in Burundi to 66% in Congo (p